Middle East and Africa Antacids Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)

No. of Pages: 141
Report Code: TIPRE00021091
Category: Life Sciences
Middle East and Africa Antacids Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East and Africa Antacids Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East and Africa Antacids Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East and Africa Antacids Market Regional Analysis

6.2 Middle East and Africa Antacids Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa Antacids Market Forecast Analysis

7. Middle East and Africa Antacids Market Analysis – by Dosage Form

7.1 Tablet
  • 7.1.1 Overview
  • 7.1.2 Tablet: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Liquid
  • 7.2.1 Overview
  • 7.2.2 Liquid: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Middle East and Africa Antacids Market Analysis – by Drug Class

8.1 Proton Pump Inhibitors
  • 8.1.1 Overview
  • 8.1.2 Proton Pump Inhibitors: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 H2 Antagonist
  • 8.2.1 Overview
  • 8.2.2 H2 Antagonist: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Acid Neutralizers
  • 8.3.1 Overview
  • 8.3.2 Acid Neutralizers: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Middle East and Africa Antacids Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy
  • 9.1.1 Overview
  • 9.1.2 Hospital Pharmacy: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Retail Pharmacy
  • 9.2.1 Overview
  • 9.2.2 Retail Pharmacy: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Online Pharmacy
  • 9.3.1 Overview
  • 9.3.2 Online Pharmacy : Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Middle East and Africa Antacids Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa
  • 10.2.1 Middle East and Africa Antacids Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.2.1.1 Middle East and Africa Antacids Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 South Africa: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.1.1 South Africa: Middle East and Africa Antacids Market Breakdown, by Dosage Form
    • 10.2.1.1.2 South Africa: Middle East and Africa Antacids Market Breakdown, by Drug Class
    • 10.2.1.1.3 South Africa: Middle East and Africa Antacids Market Breakdown, by Distribution Channel
  • 10.2.1.2 Saudi Arabia: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.2.1 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Dosage Form
    • 10.2.1.2.2 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Drug Class
    • 10.2.1.2.3 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Distribution Channel
  • 10.2.1.3 UAE: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.3.1 UAE: Middle East and Africa Antacids Market Breakdown, by Dosage Form
    • 10.2.1.3.2 UAE: Middle East and Africa Antacids Market Breakdown, by Drug Class
    • 10.2.1.3.3 UAE: Middle East and Africa Antacids Market Breakdown, by Distribution Channel
  • 10.2.1.4 Rest of Middle East and Africa: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Dosage Form
    • 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Drug Class
    • 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Bayer AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 GlaxoSmithKline plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Sanofi
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Pfizer Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Procter & Gamble
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Middle East and Africa Antacids Market

  • Bayer AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Procter & Gamble
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)